organization · Reporting owner
Leonite Capital LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pasithea Therapeutics Corp.KTTA · Entity 7685 | Member of 10% owner group | August 19, 2022 | August 26, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pasithea Therapeutics Corp.
Report date August 19, 2022 · Filed August 26, 2022
Jointly reported with Geller Avi, Leonite Fund I, LP
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 54,644 |
Reported balance
After 2022-08-19 transaction · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · 2022-08-19 · Purchase · Acquired 54,644 · Balance 54,644 F1: The shares are held by Leonite Fund I, LP. Avi Geller is the Managing Member of Leonite Advisors LLC, which is the General Partner of Leonite Fund I, LP. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 1,034,702 |
Reported balance
Holding disclosure · report date 2022-08-19 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,034,702 F2: The shares are held by Leonite Capital LLC, of which Avi Geller serves as Chief Investment Officer. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares are held by Leonite Fund I, LP. Avi Geller is the Managing Member of Leonite Advisors LLC, which is the General Partner of Leonite Fund I, LP.
F2: The shares are held by Leonite Capital LLC, of which Avi Geller serves as Chief Investment Officer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2022 Filed Aug 26, 2022 20:30 UTC | Pasithea Therapeutics Corp. KTTA · Entity 7685 | PurchaseCommon Stock | 54,644 | $1.30 | $70,938.84 |
DisclosureSEC source: 0001209191-22-047714 · doc4.xml · nonDerivative · entry 1 Geller Avi · CIK 0001883076 · Member of 10% owner group Leonite Fund I, LP · CIK 0001944053 · Member of 10% owner group Leonite Capital LLC · CIK 0001824520 · Member of 10% owner group Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 54,644 F1 · ownership.nature: The shares are held by Leonite Fund I, LP. Avi Geller is the Managing Member of Leonite Advisors LLC, which is the General Partner of Leonite Fund I, LP. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.